All sponsors

Celltrion $068270.KS

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS5
PHASE 3 / 2-35
RECRUITING2
READOUTS ≤12 MONTHS4
Open Celltrion on the live radar map → 📅 $068270.KS readout calendar (.ics)
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
CT-P55
NCT06630559
P3Active, not recruitingPlaque Psoriasis1532026-02-18 (+3 mo)
Metformin
NCT07093476
P3RecruitingT2DM; Diabete Type 21712026-12
CT-P51
NCT06939595
P3Active, not recruitingNon Squamous Non Small Cell Lung Cancer2252027-02
CT-P53
NCT05906992
P3RecruitingRelapsing-remitting Multiple Sclerosis5122027-02
CT-P44(Daratumumab)
NCT06952478
P3Active, not recruitingRefractory or Relapsed Multiple Myeloma4732027-03-08 (-8 mo)